US BANCORP \DE\ - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$577,594
-7.2%
8,599
-4.7%
0.00%0.0%
Q2 2023$622,651
-7.0%
9,020
-35.0%
0.00%0.0%
Q1 2023$669,246
+2.6%
13,879
+6.2%
0.00%0.0%
Q4 2022$652,354
+4249.0%
13,068
+3530.0%
0.00%
Q3 2022$15,000
+15.4%
360
+48.8%
0.00%
Q2 2022$13,000
+44.4%
2420.0%0.00%
Q1 2022$9,000
+125.0%
242
+195.1%
0.00%
Q4 2021$4,000
-76.5%
82
-75.3%
0.00%
Q3 2021$17,0003320.00%
Other shareholders
LEGEND BIOTECH CORP shareholders Q1 2023
NameSharesValueWeighting ↓
FengHe Fund Management Pte. Ltd. 526,072$21,595,00011.36%
Consonance Capital Management LP 1,647,497$67,630,0008.14%
Johnson & Johnson Innovation - JJDC, Inc. 1,629,173$66,878,0006.84%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,342,442$55,107,0002.29%
Vivo Capital, LLC 956,702$39,273,0001.70%
Hudson Bay Capital Management LP 1,878,374$77,107,0000.93%
Capital International Sarl 220,470$9,050,0000.78%
Capital International, Inc./CA/ 1,951,845$80,123,0000.72%
Avidity Partners Management LP 625,000$25,656,0000.69%
INDUS CAPITAL PARTNERS, LLC 94,678$3,887,0000.66%
View complete list of LEGEND BIOTECH CORP shareholders